234 related articles for article (PubMed ID: 20538611)
1. In silico docking and electrophysiological characterization of lacosamide binding sites on collapsin response mediator protein-2 identifies a pocket important in modulating sodium channel slow inactivation.
Wang Y; Brittain JM; Jarecki BW; Park KD; Wilson SM; Wang B; Hale R; Meroueh SO; Cummins TR; Khanna R
J Biol Chem; 2010 Aug; 285(33):25296-307. PubMed ID: 20538611
[TBL] [Abstract][Full Text] [Related]
2. Drug binding assays do not reveal specific binding of lacosamide to collapsin response mediator protein 2 (CRMP-2).
Wolff C; Carrington B; Varrin-Doyer M; Vandendriessche A; Van der Perren C; Famelart M; Gillard M; Foerch P; Rogemond V; Honnorat J; Lawson A; Miller K
CNS Neurosci Ther; 2012 Jun; 18(6):493-500. PubMed ID: 22672303
[TBL] [Abstract][Full Text] [Related]
3. Lacosamide: a review of preclinical properties.
Beyreuther BK; Freitag J; Heers C; Krebsfänger N; Scharfenecker U; Stöhr T
CNS Drug Rev; 2007; 13(1):21-42. PubMed ID: 17461888
[TBL] [Abstract][Full Text] [Related]
4. Activity of the anticonvulsant lacosamide in experimental and human epilepsy via selective effects on slow Na
Holtkamp D; Opitz T; Niespodziany I; Wolff C; Beck H
Epilepsia; 2017 Jan; 58(1):27-41. PubMed ID: 27864845
[TBL] [Abstract][Full Text] [Related]
5. Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine.
Sheets PL; Heers C; Stoehr T; Cummins TR
J Pharmacol Exp Ther; 2008 Jul; 326(1):89-99. PubMed ID: 18378801
[TBL] [Abstract][Full Text] [Related]
6. (S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5.
Moutal A; François-Moutal L; Perez-Miller S; Cottier K; Chew LA; Yeon SK; Dai J; Park KD; Khanna M; Khanna R
Mol Neurobiol; 2016 Apr; 53(3):1959-1976. PubMed ID: 25846820
[TBL] [Abstract][Full Text] [Related]
7. (S)-lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology.
Moutal A; Chew LA; Yang X; Wang Y; Yeon SK; Telemi E; Meroueh S; Park KD; Shrinivasan R; Gilbraith KB; Qu C; Xie JY; Patwardhan A; Vanderah TW; Khanna M; Porreca F; Khanna R
Pain; 2016 Jul; 157(7):1448-1463. PubMed ID: 26967696
[TBL] [Abstract][Full Text] [Related]
8. Inverted-U response of lacosamide on pilocarpine-induced status epilepticus and oxidative stress in C57BL/6 mice is independent of hippocampal collapsin response mediator protein-2.
Nirwan N; Siraj F; Vohora D
Epilepsy Res; 2018 Sep; 145():93-101. PubMed ID: 29935443
[TBL] [Abstract][Full Text] [Related]
9. Regulation of N-type voltage-gated calcium channels (Cav2.2) and transmitter release by collapsin response mediator protein-2 (CRMP-2) in sensory neurons.
Chi XX; Schmutzler BS; Brittain JM; Wang Y; Hingtgen CM; Nicol GD; Khanna R
J Cell Sci; 2009 Dec; 122(Pt 23):4351-62. PubMed ID: 19903690
[TBL] [Abstract][Full Text] [Related]
10. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.
Errington AC; Stöhr T; Heers C; Lees G
Mol Pharmacol; 2008 Jan; 73(1):157-69. PubMed ID: 17940193
[TBL] [Abstract][Full Text] [Related]
11. Prevention of posttraumatic axon sprouting by blocking collapsin response mediator protein 2-mediated neurite outgrowth and tubulin polymerization.
Wilson SM; Xiong W; Wang Y; Ping X; Head JD; Brittain JM; Gagare PD; Ramachandran PV; Jin X; Khanna R
Neuroscience; 2012 May; 210():451-66. PubMed ID: 22433297
[TBL] [Abstract][Full Text] [Related]
12. Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: a comparison with carbamazepine, oxcarbazepine and lacosamide.
Hebeisen S; Pires N; Loureiro AI; Bonifácio MJ; Palma N; Whyment A; Spanswick D; Soares-da-Silva P
Neuropharmacology; 2015 Feb; 89():122-35. PubMed ID: 25242737
[TBL] [Abstract][Full Text] [Related]
13. Lacosamide: a new approach to target voltage-gated sodium currents in epileptic disorders.
Curia G; Biagini G; Perucca E; Avoli M
CNS Drugs; 2009; 23(7):555-68. PubMed ID: 19552484
[TBL] [Abstract][Full Text] [Related]
14. Specific binding of lacosamide to collapsin response mediator protein 2 (CRMP2) and direct impairment of its canonical function: implications for the therapeutic potential of lacosamide.
Wilson SM; Khanna R
Mol Neurobiol; 2015 Apr; 51(2):599-609. PubMed ID: 24944082
[TBL] [Abstract][Full Text] [Related]
15. CRMP2 protein SUMOylation modulates NaV1.7 channel trafficking.
Dustrude ET; Wilson SM; Ju W; Xiao Y; Khanna R
J Biol Chem; 2013 Aug; 288(34):24316-31. PubMed ID: 23836888
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive effects of lacosamide on spinal neuronal and behavioural measures of pain in a rat model of osteoarthritis.
Rahman W; Dickenson AH
Arthritis Res Ther; 2014 Dec; 16(6):509. PubMed ID: 25533381
[TBL] [Abstract][Full Text] [Related]
17. An atypical role for collapsin response mediator protein 2 (CRMP-2) in neurotransmitter release via interaction with presynaptic voltage-gated calcium channels.
Brittain JM; Piekarz AD; Wang Y; Kondo T; Cummins TR; Khanna R
J Biol Chem; 2009 Nov; 284(45):31375-90. PubMed ID: 19755421
[TBL] [Abstract][Full Text] [Related]
18. Lacosamide, a newer antiepileptic.
Patyar S; Medhi B
Neurosciences (Riyadh); 2010 Jan; 15(1):3-6. PubMed ID: 20677583
[TBL] [Abstract][Full Text] [Related]
19. Seeking a mechanism of action for the novel anticonvulsant lacosamide.
Errington AC; Coyne L; Stöhr T; Selve N; Lees G
Neuropharmacology; 2006 Jun; 50(8):1016-29. PubMed ID: 16620882
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of lacosamide and classical sodium channel blocking antiepileptic drugs on sodium channel slow inactivation.
Niespodziany I; Leclère N; Vandenplas C; Foerch P; Wolff C
J Neurosci Res; 2013 Mar; 91(3):436-43. PubMed ID: 23239147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
